Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

• 收藏
• 分享

专利权人:

Memorial Sloan Kettering Cancer Center

发明人:

Deng, Liang,Shuman, Stewart,Wolchok, Jedd,Merghoub, Taha,Wang, Weiyi,Dai, Peihong,Yang, Ning

申请号：

AU2017222686

公开号：

AU2017222686A1

申请日:

2017.02.25

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The present invention relates generally to the fields of oncology, virology and immunotherapy. More particularly, it concerns the use of poxviruses, specifically the replication competent attenuated vaccinia virus with deletion of thymidine kinase (VC-TK

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/